Drug pricing reforms may impact Canadians’ access to medications
Despite concerns Canadian drug prices are skyrocketing, the Patented Medicines Price Review Board, Canada’s price regulator, has ensured costs for patented drugs haven’t increased more…
- By: Suzanne Lepage
- January 15, 2021 April 14, 2021
- 08:57












